NRC Health (NRC)
NASDAQ: NRC · Real-Time Price · USD
19.87
+0.36 (1.85%)
Aug 3, 2026, 10:07 AM EDT - Market open
NRC Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5.86 | 11.6 | 24.78 | 30.97 | 31.8 | 37.47 |
Depreciation & Amortization | 8.63 | 7.62 | 6.02 | 5.9 | 5.28 | 6.37 |
Stock-Based Compensation | 11.81 | 3.31 | 0.28 | 0.94 | 1.2 | 0.62 |
Other Adjustments | 2.64 | 3 | -0.28 | -0.68 | 1.34 | 0.04 |
Change in Receivables | 3.09 | -0.05 | 1.76 | 2.08 | -0.73 | 0.34 |
Changes in Accounts Payable | 0.24 | 0.17 | -0.11 | 0.18 | -0.59 | 0 |
Changes in Accrued Expenses | -0.01 | 1.67 | 0.17 | -0.81 | -2.95 | -0.29 |
Changes in Income Taxes Payable | -3.89 | -0.19 | 0.16 | 0.8 | 0.01 | 0.48 |
Changes in Unearned Revenue | 0.91 | 0.27 | 0.22 | -0.36 | -2.01 | 1.39 |
Changes in Other Operating Activities | 0.16 | -0.95 | 1.62 | -0.91 | 2.93 | -0.09 |
Operating Cash Flow | 29.51 | 26.45 | 34.63 | 38.11 | 36.27 | 46.34 |
Operating Cash Flow Growth | 38.49% | -23.61% | -9.15% | 5.10% | -21.75% | 14.05% |
Capital Expenditures | -7.87 | -10.71 | -15.45 | -15.78 | -9.84 | -5.51 |
Sale of Property, Plant & Equipment | - | - | - | 0 | - | - |
Cash Acquisitions | - | - | -4.83 | - | - | -3 |
Investing Cash Flow | -7.87 | -10.71 | -20.28 | -15.78 | -9.84 | -8.51 |
Short-Term Debt Issued | 31 | 37 | 49.5 | 15 | - | - |
Short-Term Debt Repaid | -18 | -37 | -49.5 | -15 | - | - |
Net Short-Term Debt Issued (Repaid) | 13 | -0 | 0 | 0 | - | - |
Long-Term Debt Issued | - | 47.68 | 32 | 19 | - | - |
Long-Term Debt Repaid | -4.04 | -31.42 | -5.99 | -4.53 | -4.31 | -4.09 |
Net Long-Term Debt Issued (Repaid) | -4.04 | 16.26 | 26.01 | 14.47 | -4.31 | -4.09 |
Issuance of Common Stock | 0.14 | 0.13 | - | 0.58 | - | 0.45 |
Repurchase of Common Stock | -18.85 | -20.59 | -31.26 | -19.1 | -27.81 | -4.86 |
Net Common Stock Issued (Repurchased) | -18.71 | -20.46 | -31.26 | -18.52 | -27.81 | -4.42 |
Common Dividends Paid | -12.71 | -10.98 | -11.45 | -36.37 | -20.96 | -9.16 |
Other Financing Activities | -0.73 | -0.66 | -0.06 | -0.3 | -2.51 | -0.49 |
Financing Cash Flow | -23.59 | -15.84 | -16.76 | -40.71 | -55.58 | -18.16 |
Foreign Exchange Rate Adjustments | - | - | - | -0 | -0.18 | 0 |
Net Cash Flow | -1.95 | -0.09 | -2.42 | -18.37 | -29.34 | 19.67 |
Free Cash Flow | 21.64 | 15.74 | 19.18 | 22.33 | 26.43 | 40.83 |
Free Cash Flow Growth | 133.40% | -17.90% | -14.13% | -15.50% | -35.27% | 11.40% |
FCF Margin | 15.46% | 11.46% | 13.40% | 15.03% | 17.44% | 27.60% |
Free Cash Flow Per Share | 0.99 | 0.70 | 0.81 | 0.91 | 1.06 | 1.59 |
Levered Free Cash Flow | 13 | 25.74 | 43.43 | 34.47 | 20.32 | 35.73 |
Unlevered Free Cash Flow | 7.38 | 12.57 | 19.31 | 20.06 | 27.39 | 41.09 |